Tobramycin + Fluorometholone in pharma franchise in Tripura

Tobramycin + Fluorometholone in PCD pharma franchise in Patna

Tobramycin + Fluorometholone in top pharma company in Amritsar

Tobramycin + Fluorometholone in pcd pharma supplier in Navi Mumbai

Tobramycin + Fluorometholone in phama franchise company in India
Tobramycin + Fluorometholone in phama distributor in Allahabad

Home/Products /tobramycin-0-point-3-w-v-fluorometholone-0-point-1-w-v-eye-ear-drop

Tobraxyle FML Eye Drop

Composition : Tobramycin (0.3% w/v) + Fluorometholone (0.1% w/v)

Dosage Form : Eye Drop

Packaging Type : pack

Packaging : 5ml

Price : ₹158/-

Tobraxyle FML Eye Drop combines two active ingredients, Tobramycin and Fluorometholone, to provide effective treatment for bacterial eye infections while also reducing inflammation. Tobramycin, an aminoglycoside antibiotic, works by inhibiting bacterial protein synthesis, which stops bacterial growth and helps eliminate the infection. Fluorometholone, a corticosteroid, acts as an anti-inflammatory agent, reducing swelling, redness, and discomfort associated with eye infections.

This combination is particularly effective for treating conditions such as bacterial conjunctivitis, keratitis, and other ocular infections that involve both infection and inflammation. By addressing both the bacterial cause of the infection and the inflammatory response, Tobraxyle FML ensures faster recovery and relief of symptoms such as pain, swelling, and redness.

The inclusion of Fluorometholone in this formulation helps prevent the progression of inflammation, especially in cases where inflammation could lead to further complications, such as scarring or vision problems. Tobraxyle FML Eye Drop is typically used under the guidance of an ophthalmologist to ensure proper diagnosis and treatment. It is important to follow the prescribed dosage and duration to prevent the development of antibiotic resistance or unwanted side effects from corticosteroid use.

Read More

About the Product

Tobraxyle FML Eye Drop combines two active ingredients, Tobramycin and Fluorometholone, to provide effective treatment for bacterial eye infections while also reducing inflammation. Tobramycin, an aminoglycoside antibiotic, works by inhibiting bacterial protein synthesis, which stops bacterial growth and helps eliminate the infection. Fluorometholone, a corticosteroid, acts as an anti-inflammatory agent, reducing swelling, redness, and discomfort associated with eye infections.

This combination is particularly effective for treating conditions such as bacterial conjunctivitis, keratitis, and other ocular infections that involve both infection and inflammation. By addressing both the bacterial cause of the infection and the inflammatory response, Tobraxyle FML ensures faster recovery and relief of symptoms such as pain, swelling, and redness.

The inclusion of Fluorometholone in this formulation helps prevent the progression of inflammation, especially in cases where inflammation could lead to further complications, such as scarring or vision problems. Tobraxyle FML Eye Drop is typically used under the guidance of an ophthalmologist to ensure proper diagnosis and treatment. It is important to follow the prescribed dosage and duration to prevent the development of antibiotic resistance or unwanted side effects from corticosteroid use.

Common side effects include eye irritation, burning, stinging, redness, and blurred vision. If symptoms persist or worsen, consult a healthcare professional.

Tobraxyle FML Eye Drop is indicated for the treatment of bacterial eye infections associated with inflammation, including conjunctivitis and keratitis.

Do not use beyond the prescribed duration. Discard after 28 days of opening to prevent contamination.

Store the bottle in a cool, dry place away from direct sunlight. Keep the lid tightly closed and out of the reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation